Asia-Pacific Cardiovascular Intervention and Surgical Symposium Completion...The 30th anniversary event of 3Day Seminar
Nov 25, 2025
|
This is the definition of Seo Jeong-wook, chairman of the Uchon Cardiovascular Research Foundation, who is the organizer of the event for the '2025 Asia-Pacific Cardiovascular Intervention and Surgery Symposium (APCIS)' held at the Dragon City Hotel in Seoul from the 12th to the 14th and the '3 Day Seminar on Conventional Heart Disease' which marks the 30th anniversary this year.
Chairman Suh said, "The 3-Day Seminar, the birthplace of APCIS, has celebrated its 30th anniversary" and added, "This year's event not only discussed the latest knowledge, but also implicitly included the dual goal of honoring the noble dedication of experts who have maintained the clinical foundation of the field of pediatric cardiology in Korea over the past 30 years and presenting a new vision for future generations to come."
On the occasion of the 30th anniversary of the 3-Day Seminar, Chairman Seo released a photo of the past years' joy, anger, and sorrow to the participants.
The photo is full of the passion of senior medical professionals who do not stop to train their students, from the scene of continuing the 3-Day Seminar without government support in the 1980s and 90s to the scene of focusing on education by using face shields for junior medical professionals during the recent COVID-19 pandemic.
Chairman Suh said, `APCIS and 3-Day Seminar are symbols of sacrifice and service.'" Currently, overseas participants account for 50 percent of the total, and medical professionals from both developed and developing countries are learning how to treat congenital heart disease." It has established itself as an international pediatric cardiology symposium in name and reality."
Dr. Frank Ing (UC Davis Health, USA), a world-renowned expert in pediatric cardiology, also attended the event in person and said, "It is a unique academic event that is unique in the world, and the fact that you can see various heart diseases directly with your heart and the active debate that continues beyond 10 p.m. are very impressive. Above all, it is an event that confirms the dedication of doctors to treating childhood heart disease." He also honored the achievements of the 3-Day Seminar over the past 30 years.
◇'2025 APCIS', 750 people from 19 countries participated in the event
'2025 APCIS' ended successfully with 750 participants from 19 countries around the world.
According to Sejong Hospital on the 25th, APCIS (Conference Hall Jung Sung-woon and Co-Conference Hall Oh Byung-hee) is a place where heart experts from all over the world participate to discuss comprehensive cardiovascular disease diagnosis and treatment.
Hosted by the Korean Society of Cardiovascular Thoracic Surgery (Chairman Jung Sung-woon), organized by the Uchon Cardiovascular Research Foundation (Chairman Seo Jeong-wook), and sponsored by the Korean Heart Association's Cardiology Research Society, the Korean Pediatric Heart Association, and the Hyewon Medical Foundation Sejong Hospital.
This year's APCIS was themed 'Essential Medical Services for Heart Disease'.
Participants shared their latest knowledge and heated discussions on mechanical support for the heart, including heart failure, arrhythmia, cardiac renal syndrome and heart-to-heart syndrome (LVAD), cases of surgery such as heart transplantation, congenital heart disease (CHD) and adult congenital heart disease (ACHD), Fontan, echocardiography and magnetic resonance imaging (MRI) clinical applications for pediatric heart disease patients, treatment of aortic valves, mitral valves, tricuspid valves, coronary and peripheral vascular intervention, cardiac rehabilitation, cardiac nursing, lymphatic heart failure, and country-specific clinical case discussions.
Professor Jose Pedro Da Silva of the University of Pittsburgh, a world-renowned authority in the field of pediatric heart surgery, also attended the site in person, demonstrated how to perform heart surgery using 3D models, and ran a program that participants could try.
Mayo Clinic Dr. William R. Miranda and others also participated through real-time online video connections to share the latest knowledge, including evaluating invasive catheterization of Fontan surgery, a treatment for congenital heart disease.
The real heart appeared in APCIS this year as usual. Seo Jeong-wook, chairman of the Uchon Cardiovascular Research Foundation, prepared about 200 real hearts from autopsy and heart transplantation for heart sample observation. Real heart observation is a representative difference from other academic conferences.
Chairman Suh helped understand the presentation by visually checking the appearance of fiber accumulated inside the heart, the enlarged heart, and white spots (hardened traces) throughout myocardium, as well as explaining the actual heart that suffered from heart disease.
|
In particular, the 'Three-Day Seminar (3-Day Seminar on Congenital Heart Disease)' which was the birthplace of APCIS was also held unchanged during the event.
Celebrating its 30th anniversary this year, the 3-Day Seminar is a program to train experts in congenital heart disease.
It is truly a place of pure passion and harmony for medical professionals who have lived only for pediatric heart patients, and it is the only educational site in Korea that educates while looking at the actual autopsy heart that is difficult to find around the world.
The achievements of the 30th anniversary of the 3-Day Seminar are the result of the constant support and efforts of Bucheon Sejong Hospital, the only heart hospital in Korea.
Dr. Uchon Park Young-kwan, founder of Sejong Hospital, has hosted a competitive debate on congenital heart disease held overseas to Korea in 1995 and has continued to this day. Over the past 30 years, 2,48 medical professionals have participated worldwide.
The role of pediatric cardiologist in cardiology, pediatric and cardiovascular thoracic surgery is important for the treatment of congenital heart disease. And they should be educated steadily, and it is essential to secure an autopsy heart for education.
Since the establishment of Sejong Hospital in 1982, Dr. Uchon Park Young-kwan has devoted himself to recording and researching all the processes from diagnosis, surgery, and postoperative treatment of heart disease through the use of a autopsy.
To win the heart of a heart patient who died for research, he had to be ready to be slapped. The medical staff at Sejong Hospital sincerely persuaded the patient's guardians for the study, and the guardians, who initially stubbornly refused to perform autopsy, also said they would reduce the number of patients who die by studying heart disease"I was moved by the willingness of the enthusiastic doctors to persuade them and agreed.
The cause of death was revealed and organized in detail by recreating the entire process, including diagnosis and surgery, with the autopsy heart collected so hard, which became the basis of the 3-Day Seminar.
Chairman Suh explained that `The analysis of failure cases through autopsy and the establishment of knowledge through clinical and pathological discussions led to the growth of medical staff's education, academic research, and medical technology, and the treatment results of Sejong Hospital's congenital heart disease treatment results grew to a world-class level.' The international academic program started in 1995 to share the accumulated knowledge.
The 3-Day Seminar is a method in which young professors majoring in congenital heart disease, full-time doctors, and doctors from around the world participate in a team to review actual patient treatment videos and treatment cases such as surgery, and compete for congenital heart disease until late at night for three days. In this process, the mentor and mentee relationship between seniors and juniors works strongly.
The key difference between the 3-Day Seminar and other academic conferences is that it continuously manages the real heart legally acquired through autopsy and heart transplantation and uses it for academic research, discussion, and education by clinical doctors.
More than 150 cardiologists working at medical institutions such as Korea, the United States, Japan, Taiwan, Vietnam, Uzbekistan, India, Poland, Thailand, Mongolia, Saudi Arabia, and Malaysia participated in this year's competitive debate.
◇APCIS, medical specialists, nurses, and future generations of medical professionals are also educated
APCIS also focused on strengthening nursing capacity. Every year, nurses from Bucheon Sejong Hospital and Incheon Sejong Hospital participate and share the latest knowledge.
This year, the theme was advanced cardiovascular care, including emergency response, monitoring, and intervention. In detail, the development of an emergency response system for acute aortic dissection and nursing roles, the changing role and future prospects of nurses in cardiac implantation electronics (CIED) experiments, and a case study of early cardiac arrhythmia intervention using a continuous monitoring system operated by a rapid response team were discussed.
APCIS also organized a two-day special lecture on congenital heart disease and an education program to observe the autopsy heart.
About 200 people, including future medical professionals such as Gachon University, Catholic Sangji University, Kangwon National University, Kyungbok University, Kyungin Women's University, and Talent University, participated in the education and exchanged candid questions and answers with senior medical professionals.
In addition, they provided special education for doctors and shared the latest knowledge on extracorporeal circulation, which is essential for heart surgery.
APCIS is also the home of global medical devices and pharmaceutical companies.
This year, Medical AI, Celltrion Pharmaceutical, Yuhan Corporation, Boryung Pharmaceutical, Hanmi Pharmaceutical, Daewoong Pharmaceutical, Chong Kun Dang, Samjin Pharmaceutical, Anguk Pharmaceutical, Korea Servier, Otsuka Pharmaceutical, Korea Daiichi Sankyo, U-FineMed, Korea BMS, Donghwa Pharmaceutical, AstraZeneca, Korea Uniparm, Handok Pharmaceutical, JW Pharmaceutical, JW Life Sciences, Hallym Pharmaceutical, Korea Dakeda, Dong-A ST, HKINON, Evot, Bayer Korea, Daewon Pharmaceutical, Sanofi Korea, Biatris Korea, COBMD, Novartis
"The heart literally plays an important role in supporting human life," said Jeong Seong-woon, president of APCIS. APCIS is also playing a role in supporting the passion for heart therapy, particularly focusing on nurturing the younger generation"We look forward to a lot of participation in APCIS, which is leading the development of basic science, medical technology, and clinical medicine in the heart field."
Oh Byung-hee, co-chairman of APCIS (President of Sejong Hospital in Incheon), said "Only when basic and clinical medical education and training are continuously conducted can we provide the highest level of medical services."APCIS and 3-Day Seminar have long enhanced the capacity of healthcare workers in the heart sector. We will continue to lead the development of global cardiology through fierce discussions and case sharing," he said.
This article was translated by Naver AI translator.
